Premature stopping of LEIA-HF: protecting trial participants while preserving clinical knowledge

ESC Heart Failure · Published 2026-05-05 · DOI 10.1093/eschf/xvag164

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1093/eschf/xvag164

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Real-World Evaluation of Individualised Natriuresis and Diuresis Driven Protocol for Decongestion in Acute Heart Failure · ESC Heart Failure · 2026 · Same journal
• Cardiac amyloidosis with apical myocardial infarction: beyond the cherry on top · ESC Heart Failure · 2026 · Same journal
• Interaction of secondary ventricular tricuspid regurgitation with RV in HFREF: an invasive pressure-volume loop study · ESC Heart Failure · 2026 · Same journal
• Cost-effectiveness of TTVR with EVOQUE system in patients with Severe Tricuspid Regurgitation based on TRISCEND II trial · ESC Heart Failure · 2026 · Same journal
• FEV1 is a major prognostic factor in diverse heart failure populations: findings from the Global Heart Failure registry · ESC Heart Failure · 2026 · Same journal
• Frailty and Heart Failure: An Integrated Review of a Bidirectional Relationship · ESC Heart Failure · 2026 · Same journal
• Left atrial remodelling and diastolic unloading after transcatheter tricuspid repair · ESC Heart Failure · 2026 · Same journal
• Unaccounted immunosuppression and absent donor data limit infection risk after high-urgency heart transplantation · ESC Heart Failure · 2026 · Same journal
• Interplay Between Acute Heart Failure and COPD in Patients Hospitalized for Dyspnea: Prognostic Insights From the PARADISE Cohort · ESC Heart Failure · 2026 · Same journal
• Stratifying prognosis in heart failure patients with reduced ejection fraction and atrial cardiomyopathy · ESC Heart Failure · 2026 · Same journal